BiotechTube
Home/ENA Respiratory/Ruth Tal‑Singer, PhD
RT

Ruth Tal‑Singer, PhD

Medicine Development Leader

ENA Respiratory

Therapeutic Areas

Respiratory Infectious DiseasesImmunology

ENA Respiratory Pipeline

DrugIndicationPhase
INNA-051Prophylaxis against viral respiratory infections (e.g., SARS‑CoV‑2, influenza, rhinovirus)Phase 2

Leadership Team at ENA Respiratory

CD
Christophe Demaison, PhD
CEO
CC
Courtney Crim, MD
Chief Medical Officer
View full ENA Respiratory profile